pleurotus eryngii extract
Botanicalexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Nov 1, 2008 (NCT01402115)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pleurotus eryngii extractx
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05446610 | N/A | Mar 17, 2020 | Agricultural University of Athens, Harokopio University, National Hellenic Research Foundation, Orebro University |
| NCT01402115 | Phase 2/Phase 3 (Phase 3) | Nov 1, 2008 | Chonbuk National University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Agricultural University of Athens | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Chonbuk National University | Academic/Hospital | 1 | 1 | 1 | 2008 |
| Harokopio University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| National Hellenic Research Foundation | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Orebro University | Academic/Hospital | 1 | 1 | 1 | 2020 |
5 organizations
Page 1 / 1